glp-1 cardiovascular outcomes news today and mortality with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Cardiovascular outcomes in major trials

The key is to identify what is limiting fat metabolism in the first place

A very large fraction of published binding constants for melanocortin ligands, including those for cyclic analogues, peptidomimetics and candidate subtype-selective compounds, are reported as inhibition of I-NDP-alpha-MSH binding to membranes from cell lines stably expressing a single human receptor subtype

facebook.com/share/p/1JWEj8 Join the conversation

Despite the decline among population-attributable fractions, smoking remained the main risk factor for mens gastric cancer in 2012, where the incidence is substantially higher in 2020 (63)

Tsai YC, Kuo CY

A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care